However, one of the difficulties of TCR-like CAR is that the target peptide and its associated HLA allele vary in different patients and cancers (e.g., WT1235-243/HLA-A*2402 (16) or WT1126-134/HLA-A*02:01 (17)). This evidence concerns the gene HLA-A and cancer.